Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15

Ordered mesoporous materials exhibit potential features to be used as controlled drug delivery systems, including their wide range of chemical compositions and their outstanding textural and structural properties. Therefore, it is possible to control the drug release kinetics by tailoring such parameters. In this paper, mesoporous materials such as MCM-48 and SBA-15, which present different pore sizes (3.7 and 8.8 nm) and structural characteristics (3D-bicontinuous cubic and 2D-hexagonal, respectively) have been synthesized to evaluate their application as drug delivery system and to determine their influence on release kinetic of ibuprofen. Moreover, a chemical modification of the SBA-15 mesoporous material with octadecyltrimethoxysilane has also been performed to study its influence on the release rate of ibuprofen. The structural characteristics (3D cubic and 2D hexagonal pore system) do not affect the release kinetic profiles of ibuprofen. On the contrary, the pore size affects highly to the release kinetic profiles from first-order kinetic to zero-order kinetic for MCM-48 and SBA-15, respectively. Moreover, the importance of surface functionalization was demonstrate through the very fast delivery of ibuprofen from SBA-15 mesoporous materials functionalized with octadecyl chains.

[1]  J. S. Beck,et al.  Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism , 1992, Nature.

[2]  M. Vallet‐Regí,et al.  Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage , 2008 .

[3]  Bénédicte Lebeau,et al.  Chemical strategies to design textured materials: from microporous and mesoporous oxides to nanonetworks and hierarchical structures. , 2002, Chemical reviews.

[4]  Ji Man Kim,et al.  Synthesis of MCM-48 single crystals , 1998 .

[5]  M. Vallet‐Regí,et al.  Calcium sulphate-based cements containing cephalexin. , 2004, Biomaterials.

[6]  V. Lehto,et al.  Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[7]  A. Lapkin,et al.  Preparation and characterisation of chemisorbents based on heteropolyacids supported on synthetic mesoporous carbons and silica , 2003 .

[8]  K. Hidajat,et al.  Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[9]  María Vallet-Regí,et al.  Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. , 2006, Chemistry.

[10]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[11]  P. Costa,et al.  Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  M. Jaroniec,et al.  Adsorption Study of Surface and Structural Properties of MCM-41 Materials of Different Pore Sizes , 1997 .

[13]  Jackie Y. Ying,et al.  SYNTHESIS AND APPLICATIONS OF SUPRAMOLECULAR-TEMPLATED MESOPOROUS MATERIALS , 1999 .

[14]  M. Vallet‐Regí,et al.  Encapsulation of Ibuprofen in Mesoporous Silica: Solid State NMR Characterization , 2003 .

[15]  I. Aksay,et al.  Silica Gels with Tunable Nanopores through Templating of the L3 Phase , 2000 .

[16]  R. Langer,et al.  Selected advances in drug delivery and tissue engineering. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Yasuhiro Sakamoto,et al.  Three-dimensional structure of large-pore mesoporous cubic Ia3d silica with complementary pores and its carbon replica by electron crystallography. , 2004, Angewandte Chemie.

[18]  M. Jaroniec,et al.  Application of large pore MCM-41 molecular sieves to improve pore size analysis using nitrogen adsorption measurements , 1997 .

[19]  M. Vallet‐Regí,et al.  Bioceramics and pharmaceuticals: A remarkable synergy , 2007 .

[20]  O. Terasaki,et al.  Direct observation of 3D mesoporous structure by scanning electron microscopy (SEM): SBA-15 silica and CMK-5 carbon. , 2003, Angewandte Chemie.

[21]  María Vallet-Regí,et al.  Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. , 2006, Journal of the American Chemical Society.

[22]  Patrick Augustijns,et al.  Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  M. Vallet‐Regí,et al.  Release evaluation of drugs from ordered three-dimensional silica structures. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  M. Vallet‐Regí,et al.  Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .

[25]  R. Williford,et al.  Hybrid nanogels for sustainable positive thermosensitive drug release. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Jean-Marie Devoisselle,et al.  Solid-State NMR Study of Ibuprofen Confined in MCM-41 Material , 2006 .

[27]  K. Kuroda,et al.  The preparation of alkyltrimethylammonium-kanemite complexes and their conversion to microporous materials. , 1990 .

[28]  Fredrickson,et al.  Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores , 1998, Science.

[29]  M. Vallet‐Regí,et al.  MCM-41 Organic Modification as Drug Delivery Rate Regulator , 2003 .

[30]  M. Vallet‐Regí,et al.  Drug confinement and delivery in ceramic implants. , 2007, Drug metabolism letters.

[31]  Anna Carlsson,et al.  Structural study of mesoporous MCM-48 and carbon networks synthesized in the spaces of MCM-48 by electron crystallography , 2002 .

[32]  F. Babonneau,et al.  Solid-State NMR Characterization of the Surfactant−Silica Interface in Templated Silicas: Acidic versus Basic Conditions , 2007 .

[33]  M. Vallet‐Regí,et al.  Mesoporous MCM-41 as Drug Host System , 2003 .

[34]  Bradley F. Chmelka,et al.  Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures , 1998 .

[35]  YanagisawaTsuneo,et al.  The Preparation of Alkyltriinethylaininonium–Kaneinite Complexes and Their Conversion to Microporous Materials , 2006 .

[36]  María Vallet-Regí,et al.  Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern , 2006 .

[37]  T Kitsugi,et al.  Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. , 1990, Journal of Biomedical Materials Research.

[38]  M. Vallet‐Regí,et al.  Solid State NMR Characterisation of Encapsulated Molecules in Mesoporous Silica , 2004 .

[39]  Bruce Dunn,et al.  Synthesis of sol-gel encapsulated heme proteins with chemical sensing properties , 1999 .

[40]  F. Schüth,et al.  Comparison of an ordered mesoporous aluminosilicate, silica, alumina, titania and zirconia in normal-phase high-performance liquid chromatography , 1996 .